Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Brooks Laboratories Ltd.
₹72.62
₹72.13
₹76.49
₹58.35
₹164.02
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 16.57 | 23.45 | 25.51 | 23.32 | 38.45 |
| Operating Expense | 15.83 | 20.93 | 22.38 | 21.74 | 36.59 |
| Operating Profit | 0.73 | 2.52 | 3.13 | 1.58 | 1.86 |
| Depreciation | 0.39 | 0.39 | 0.39 | 0.39 | 0.78 |
| Interest | 0.16 | 0.28 | 0.30 | 0.26 | 0.45 |
| Tax | 0 | 0 | 0 | 0.18 | 0 |
| Net Profit | 0.30 | 2.24 | 2.65 | 1.37 | 0.72 |
₹72.62
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 63.6 | 59.1 | 52.6 | 52.6 | 52.6 | 52.6 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.1 |
| DII | 3.9 | 3.9 | 10.4 | 10.4 | 10.4 | 10.4 |
| Public | 32.5 | 37.1 | 37 | 37 | 37 | 36.9 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 13.48 K | 18.54 K | 72.72% |
| Week | 25.21 K | 59.41 K | 42.43% |
| 1 Month | 44.09 K | 1.05 L | 42.15% |
| 6 Month | 35.92 K | 62.68 K | 57.31% |
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Undervalued Growth Stocks
Relative Outperformance versus Industry over 1 Month
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹8.43 | ₹104 | ₹115.35 | ₹604 | ₹791.10 | ₹690 |
| % Change | 4.98% | -1.38% | -3.98% | -1.99% | -2.37% | 3.06% |
| Revenue TTM (₹ Cr) | ₹104.12 | ₹282.74 | - | ₹488.20 | ₹588.52 | ₹1,496.96 |
| Net Profit TTM (₹ Cr) | ₹-24.37 | ₹15.30 | - | ₹56.90 | ₹101.60 | ₹132.41 |
| PE TTM | -2.90 | 26.50 | - | 30.70 | 36.00 | 29.60 |
| 1 Year Return | 743 | -17.19 | 27.77 | 0.89 | 41.16 | -12.8 |
| ROCE | -5.63 | - | - | 23.87 | 9.34 | 14.12 |
Valiant Laboratories Ltd.
₹ 59.10
+1.37%
Sigachi Industries Ltd.
₹ 21.22
-3.68%
Windlas Biotech Ltd.
₹ 774.00
-0.82%
Vineet Laboratories Ltd.
₹ 31.51
-1.62%
Solara Active Pharma Sciences Ltd.
₹ 472.60
+0.23%
Zim Laboratories Ltd.
₹ 72.00
+1.72%
Medico Remedies Ltd.
₹ 48.00
+4.53%
Dishman Carbogen Amcis Ltd.
₹ 182.40
+0.07%
Lasa Supergenerics Ltd.
₹ 8.05
+2.42%
Advanced Enzyme Technologies Ltd.
₹ 313.00
+0.02%
Bajaj Healthcare Ltd.
₹ 348.00
-1.29%
Ortin Global Ltd.
₹ 18.91
-4.97%
RPG Life Sciences Ltd.
₹ 1915.00
+0.59%
Bafna Pharmaceuticals Ltd.
₹ 111.50
-1.11%
Alpa Laboratories Ltd.
₹ 68.45
+2.30%
Sun Pharma Advanced Research Company Ltd.
₹ 127.75
-1.13%
SMS Pharmaceuticals Ltd.
₹ 375.20
+0.74%
Nectar Lifesciences Ltd.
₹ 12.70
+0.63%
Mangalam Drugs and Organics Ltd.
₹ 31.15
-1.61%
Indoco Remedies Ltd.
₹ 200.10
+0.93%
Ind-Swift Laboratories Ltd.
₹ 146.60
+3.32%
Lincoln Pharmaceuticals Ltd.
₹ 619.00
-0.58%
Panacea Biotec Ltd.
₹ 338.80
-0.79%
By signing up I certify terms, conditions & privacy policy